前交叉韧带重建中缝线带增强:一项前瞻性随机对照试验(STACLR)
该试验为单中心、平行臂、1:1 分配的随机对照试验,计划纳入 66 例 18 岁及以上因前交叉韧带损伤等待初次重建的患者,比较缝线带增强重建与标准重建技术。主要结局为术后 24 个月 GNRB 关节测量仪测得的胫骨前移侧间差值,次要结局包括患者报告结局、并发症及重返运动等。
要点
- 拟纳入 66 例 18 岁以上初次前交叉韧带重建患者,1:1 随机分组。
- 主要结局为术后 24 个月 GNRB 关节测量仪测得的胫骨前移侧间差值。
- 患者及进行关节测量的人员对分组设盲。
核心结论
- 该研究将是首个探讨缝线带增强前交叉韧带重建对客观或主观结局影响的随机试验。
- 试验假设为缝线带增强单束前交叉韧带重建可减少残余膝关节松弛并改善 2 年随访时的患者报告结局。
研究设计与样本
- 单中心、平行臂、1:1 分配比例的随机对照试验,计划纳入 66 例 18 岁及以上等待初次前交叉韧带重建的患者。
- 排除需要截骨和关节外腱固定术的患者,以及既往对侧前交叉韧带断裂或半月板、软骨病理修复会改变术后康复的患者。
- 参与者及进行关节测量的人员对分组设盲。
主要发现
- 该文为试验方案,尚未报告结局数据。
- 缝线带增强前交叉韧带重建在生物力学和动物水平研究中显示出前景,并发症谱与标准技术相当,初步非对照临床研究确定了该技术可能的优势领域。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Anterior cruciate ligament (ACL) reconstruction aims to restore anteroposterior and rotatory stability to the knee following ACL injury. This requires the graft to withstand the forces applied during the process of ligamentisation and the rehabilitative period. We hypothesise that the use of suture tape augmentation of single bundle ACL reconstruction (ACLR) will reduce residual knee laxity and improve patient-reported outcomes at 2-year follow-up. We will conduct a 1:1 parallel arm single-centre randomised controlled trial comparing suture tape augmented ACLR to standard ACLR technique. METHODS: The study design will be a parallel arm 1:1 allocation ratio randomised controlled trial. Sixty-six patients aged 18 and over waitlisted for primary ACLR will be randomised. Patients requiring osteotomy and extra-articular tenodesis and who have had previous contralateral ACL rupture or repair of meniscal or cartilage pathology that modifies the post-operative rehabilitation will be excluded. The primary outcome measure will be the side-to-side difference in anterior tibial translation (measured on the GNRB arthrometer) at 24 months post-surgery. GNRB arthrometer measures will also be taken preoperatively, at 3 months and 12 months post-surgery. Secondary outcomes will include patient-reported outcome measures (PROMs) collected online, including quality of life, activity and readiness to return to sport, complication rates (return to theatre, graft failure and rates of sterile effusion), examination findings and return to sport outcomes. Participants will be seen preoperatively, at 6 weeks, 3 months, 12 months and 24 months post-surgery. Participants and those taking arthrometer measures will be blinded to allocation. DISCUSSION: This will be the first randomised trial to investigate the effect of suture-tape augmentation of ACLR on either objective or subjective outcome measures. The use of suture-tape augmentation in ACLR has been associated with promising biomechanical and animal-level studies, exhibiting equivalent complication profiles to the standard technique, with initial non-comparative clinical studies establishing possible areas of advantage for the technique. The successful completion of this trial will allow for an improved understanding of the in situ validity of tape augmentation whilst potentially providing a further platform for surgical stabilisation of the ACL graft. TRIAL REGISTRATION: Australia New Zealand Clinical Trial Registry ACTRN12621001162808. Universal Trial Number (UTN): U1111-1268-1487. Registered prospectively on 27 August 2021.
引用
- Huntington L, Griffith A, Spiers L, et al. Suture-tape augmentation of anterior cruciate ligament reconstruction: a prospective, randomised controlled trial (STACLR). Trials. 2023. PMID: 36964584. doi:10.1186/s13063-023-07127-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。